Emerging therapies in the treatment of Clostridium difficile-associated disease.

@article{Jodlowski2006EmergingTI,
  title={Emerging therapies in the treatment of Clostridium difficile-associated disease.},
  author={Tomasz Z Jodlowski and Richard Oehler and Linda W Kam and Igor Melnychuk},
  journal={The Annals of pharmacotherapy},
  year={2006},
  volume={40 12},
  pages={2164-9}
}
OBJECTIVE To describe emergent therapies, such as rifaximin, nitazoxanide, intravenous immunoglobulin (IVIG), tinidazole, tolevamer, and the possible use of a vaccine, in Clostridium difficile-associated disease (CDAD), one of the most common causes of diarrhea in hospitalized adults in North America. DATA SOURCES A literature search was performed using MEDLINE (1996-October 2006), PubMed (1996-October 2006), abstracts from Infectious Diseases Society of America (September 2006) and… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 14 extracted citations

Similar Papers

Loading similar papers…